Boston Scientific to pay J&J $1.72 billion on US coronary stent dispute
This article was originally published in Scrip
Executive Summary
Boston Scientific is to pay $1.72 billion to Johnson & Johnson's Cordis unit to settle several US patent disputes on coronary stents and related intellectual property.